Skip to main content Skip to main navigation menu Skip to site footer

Low serum irisin levels in newly diagnosed patients with type 2 diabetes mellitus: a meta-analysis


Background: Low irisin levels, a marker widely reported to be associated with developing insulin resistance and type 2 diabetes mellitus. This study aims to provide evidence regarding irisin levels in patients newly diagnosed with type 2 diabetes mellitus.

Methods: A systematic review and meta-analysis of observational studies in adults over 18 newly diagnosed with type 2 diabetes mellitus. The databases used for this study were PubMed, ProQuest and ScienceDirect. Only English studies were considered in the database searched from the beginning to October 2022. The data obtained were analyzed using the RevMan 5.4 application.

Results: Twelve studies met the inclusion criteria. These were identified using a total of 1,621 patients with; 880 cases and 741 controls. This main point shows that the serum irisin level in patients newly diagnosed with type 2 diabetes mellitus has a mean difference of -7.72 with 95% CI -9.49 to -5.95. Since the evidence collected in our meta-analysis showed heterogeneity (I2 = 99%), a random effects model was performed. The z-test results for the overall effect were statistically significant (P≤0.001).

Conclusion: Irisin levels were significantly lower in patients newly diagnosed with type 2 diabetes mellitus than in the healthy group.


  1. International Diabetes Federation. Type 2 diabetes. In: IDF Diabetes Atlas. 10th ed. 2021.
  2. Defronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58(4):773–95.
  3. Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR, Aguilar RB. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema. Diabetes Care. 2016;39(2):179–86.
  4. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1α-dependent myokine that drives browning of white fat and thermogenesis. Nature. 2012;481(7382):463.
  5. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeiras AB, et al. FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine. Luque RM, editor. PLoS One. 2013;8(4):e60563.
  6. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, et al. Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance. J Clin Endocrinol Metab. 2013;98(4):E769–78.
  7. Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13(6):324–37.
  8. Stanford KI, Middelbeek RJW, Townsend KL, An D, Nygaard EB, Hitchcox KM, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest. 2013;123(1):215–23.
  9. Liu JJ, Wong MDS, Toy WC, Tan CSH, Liu S, Ng XW, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013 Jul 1;27(4):365–9.
  10. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013 Apr 1;100(1):96–101.
  11. Shelbaya S, Abu Shady MM, Nasr MS, Bekhet MM, Mageed YA-A, Abbas M. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy. Curr Diabetes Rev. 2018 Jan 2;14(5):481–6.
  12. Shoukry A, Shalaby SM, El-Arabi Bdeer S, Mahmoud AA, Mousa MM, Khalifa A. Circulating serum irisin levels in obesity and type 2 diabetes mellitus. IUBMB Life. 2016;68(7):544–56.
  13. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome. J Clin Endocrinol Metab. 2013;98(12):4899.
  14. Park MJ, Kim D Il, Choi JH, Heo YR, Park SH. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro. Cell Signal. 2015;27(9):1831–9.
  15. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63(2):514–25.
  16. Liu S, Du F, Li X, Wang M, Duan R, Zhang J, et al. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells. PLoS One. 2017;12(4).
  17. Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Clin Sci. 2015;129(10):839–50.
  18. Xin C, Liu J, Zhang J, Zhu D, Wang H, Xiong L, et al. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway. Int J Obes 2016 403. 2015;40(3):443–51.
  19. Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F, et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol Cell Cardiol. 2015 Oct 1;87:138–47.
  20. Wang Q, Ma L, Zhang Y, Zhang L, An Y, Liu J, et al. Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Ther. 2021;12(4):1029–39.
  21. Wang X, Hu T, Ruan Y, Yao J, Shen H, Xu Y, et al. The Association of Serum Irisin with Bone Mineral Density and Turnover Markers in New-Onset Type 2 Diabetic Patients. Int J Endocrinol. 2022;2022.
  22. Yildiz Kopuz TN, Dagdeviren M, Fisunoglu M. Serum irisin levels in newly diagnosed type-II diabetic patients: No association with the overall diet quality but strong association with fruit intake. Clin Nutr ESPEN. 2022;49:357–64.
  23. Song R, Zhao X, Zhang D, Wang R, Feng Y. Lower levels of irisin in patients with type 2 diabetes mellitus: A meta-analysis. Diabetes Res Clin Pract. 2021;175:108788.
  24. Du X -l., Jiang W -x., Lv Z -t. Lower Circulating Irisin Level in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis. Horm Metab Res. 2016;48(10):644–52.
  25. Zhang C, Ding Z, Lv G, Li J, Zhou P, Zhang J. Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis. J Diabetes. 2016;8(1):56–62.
  26. Xiang L, Xiang G, Yue L, Zhang J, Zhao L. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis. 2014;235(2):328–33.
  27. Balaban YA, Yilmaz N, Kalayci M, Unal M, Turhan T. Irisin and chemerin levels in patients with type 2 diabetes mellitus. Acta Endocrinol (Copenh). 2019;15(4):442–6.
  28. Yang M, Chen P, Jin H, Xie X, Gao T, Yang L, et al. Circulating levels of irisin in middle-Aged first-degree relatives of type 2 diabetes mellitus-correlation with pancreatic β-cell function. Diabetol Metab Syndr. 2014;6(1):1–7.
  29. Tang S, Zhang R, Jiang F, Wang J, Chen M, Peng D, et al. Circulating irisin levels are associated with lipid and uric acid metabolism in a Chinese population. Clin Exp Pharmacol Physiol. 2015;42(9):896–901.
  30. Xie X, Gao T, Yang M, Chen P, Jin H, Yang L, et al. Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance. Diabetol Metab Syndr. 2015;7(1):1–8.
  31. Satyarsa AB. Potential effects of alkaloid vindolicine substances in tapak dara leafs (Catharanthus roseus (L.) G. Don) in reducing blood glucose levels. Journal of Medicine and Health. 2019;2(4).
  32. Yavuz A, Isik Saglam ZM, Kavak Yavuz E, Dogruel Yilmaz M, Degerli E, Karaali Z. Serum Irisin Levels in Newly Diagnosed Type 2 Diabetes Mellitus and Prediabetic Patients. Selcuk Tip Derg. 2022;38(1):16–21.

How to Cite

Nurcahya, I. G. N. M., Paramitha, A. A. P. ., Putrawan, I. B. I. W. ., & Wulandari, D. C. . (2023). Low serum irisin levels in newly diagnosed patients with type 2 diabetes mellitus: a meta-analysis. Intisari Sains Medis, 14(1), 183–184.




Search Panel

I Gusti Ngurah Metta Nurcahya
Google Scholar
ISM Journal

Ayu Agung Pradnya Paramitha
Google Scholar
ISM Journal

Ida Bagus Indra Wibawa Putrawan
Google Scholar
ISM Journal

Dewi Catur Wulandari
Google Scholar
ISM Journal